Do not worry about the fall now. Open offer about to end and. So the surge created by open offer will smooth en and stock will get settled post open offer price soon.

A reflection of fall can be seen in September/October future price also. But these futures do not have anything to do with open offer. I think public got panicked by seeing price fall of stock market price. Future price already started recovering. ...

You are wrong. Once the open offer closed, the price will be adjusted to around Rs. 400+ level. There will not be a jump September future as the open offer is already closed and price will be valued as per Ranbaxy market value....

Clearly Ranbaxy is worth more than Rs. 400.
But too much unclear things happen here.

1: Current promoters exit their stake 100 %. This gives lack of confidence to the inverters over company management. If they believe company doing well (and will do well in future), why they exit 100% in one short?

2: How synergy will be play out after integration after merger with daichi?

3: Do DDaichi have any vested interest which can affect Ranbaxy prospects for short term?

4: Also need to find out final judgment from FDA.

5: Current market condition is very bad.

Combining all these factors, Sep 4 series trade at very cheap level of 400.

I believe all these concerns should be short term. Diiachi (when they pay huge premium to acquire Ranbaxy) should have clear long term view about how to use Ranbaxy. Once daichi speak out and implement their plan and integration, stocks should recover to s. 500 level again.

Again coming to your question \\\\...

This is product company and hence cannot directly compare with other IT companies. Deal from Ford and 133 total customers shows they do business well. Mid-cap companies were avoided by market for last few months. Again FIIs sold a total of about 10 % of company stock in Q1. You can see in share holding pattern where FII holding came from 13.29% to 3.7%. This put lot of pressure on stock. Recently mutual fund holding came up and looks like stock is back on track....

when will the ranbaxy's price fall to 400 ? I heard people saying that it will fall to 400 after the ex-date , so do we infer that tommorow we are going to see a huge fall in Ranbaxy please advise...

on what basis spot price will be adjusted to 400 + level ? you need some data points like how much daichi has accepted etc. without this its like a shot in the dark...

if the open offer is under subscribed then daichii will increase its price. on top of that the promoters will sell their stake at 742 rs per share and hence the september and october future price will go up by atleast 100 rs during that day. so it is better to wait and watch. Experience boarders can share their views on this. GRB...